Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients - Top-Institutions - MDSpire

Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients

  • By

  • Joris Holtrop

  • Mari Nordbø Gynnild

  • Toril Dammen

  • Håvard Dalen

  • Ingvild Saltvedt

  • Hanne Ellekjær

  • Steven H J Hageman

  • Frank L J Visseren

  • John William McEvoy

  • Jannick A N Dorresteijn

  • John Munkhaugen

  • On behalf of the UCC-SMART study group

  • August 26, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    University Medical Center Utrecht
    University Medical Center Utrecht

    Utrecht, Utrecht

    Key Differentiators

    • Cardiology
    • Epidemiology
    • Behavioral Medicine

  • #2

    Norwegian University of Science and Technology (NTNU)
    Norwegian University of Science and Technology (NTNU)

    Trondheim, Trøndelag

    Key Differentiators

    • Cardiology
    • Public Health
    • Psychiatry

  • #3

    Oslo University Hospital
    Oslo University Hospital

    Oslo, Oslo

    Key Differentiators

    • Cardiology
    • Neurology
    • Psychiatry

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Cardiology
    • Behavioral Medicine
    • Epidemiology

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Cardiology
    • Psychiatry
    • Preventive Medicine

Original Source(s)

Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients

  • by Joris Holtrop, Mari Nordbø Gynnild, Toril Dammen, Håvard Dalen, Ingvild Saltvedt, Hanne Ellekjær, Steven H J Hageman, Frank L J Visseren, John William McEvoy, Jannick A N Dorresteijn, John Munkhaugen, On behalf of the UCC-SMART study group

  • August 26, 2025

Related Content

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Mind Matters: Mental Health and Diabetes Management

GLP-1 Drugs Examined in Psychiatric Outcomes

Researchers evaluate mental health trajectories with antidiabetic therapies in patients with depression or anxiety.